[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2016-003446-86"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "LN-145",
            "Cell Therapy",
            "Autologous Adoptive Cell Transfer",
            "Autologous Adoptive Cell Therapy",
            "Cellular Immuno-therapy",
            "Tumor Infiltrating Lymphocytes",
            "TIL",
            "IL-2",
            "LN-145-S1"
        ],
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Iovance Biotherapeutics, Inc.",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Must be greater than 18 years of age at the time of consent."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Must have recurrent and/or metastatic, squamous cell carcinoma of the head and neck (both HPV-positive and -negative)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Must have at least 1 lesion that is resectable for TIL generation."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Must have measurable disease as defined by RECIST v1.1 following the surgical resection."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Must have received at least 1 and no more than 3 lines of prior systemic immunotherapy and/or chemotherapeutic treatments for HNSCC."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Any prior therapy directed at the malignant tumor must be discontinued at least 28 days prior to lymphodepletion."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Patients must be seronegative for the human immunodeficiency virus."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Patients seropositive for hepatitis B virus surface antigen (HBsAg), hepatitis B core antibody (anti-HBc), or hepatitis C virus (anti-HCV) indicating acute or chronic infection may be enrolled if the viral load by polymerase chain reaction (PCR) is undetectable with/without active treatment"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Patients of childbearing potential and patients whose sexual partners are of childbearing potential must be willing to practice an approved method of highly effective birth control starting at the time of informed consent and for 1 year after the completion of the study treatment regimen."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 10,
                    "description": "Patients who have received an organ allograft or prior cell transfer therapy within the past 20 years."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "Patients who are on a systemic steroid therapy (greater than 10 mg of prednisone or equivalent). Patients receiving steroids as replacement therapy for adrenocortical insufficiency at < 10 mg of prednisone or other steroid equivalent daily may be eligible."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "Prior therapy-related toxicities Grade \u2265 1 according to Common Toxicity Criteria for Adverse Events (CTCAE) v4.03"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Patients with documented Grade \u2265 2 diarrhea or colitis as a result of previous immunotherapy within six months from screening."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Patients who have a contraindication to or history of hypersensitivity reaction to cyclophosphamide, mesna, fludarabine, IL-2, antibiotics of the aminoglycoside group (ie, gentamicin or streptomycin; excluding those who are skin-test negative for gentamicin hypersensitivity), any component of the TIL infusion product formulation including dimethylsulfoxide (DMSO), human serum albumin (HSA), IL-2, and dextran-40."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Patients with active systemic infections, coagulation disorders or other active major medical illnesses of the cardiovascular, respiratory or immune system."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Patients with symptomatic and/or untreated brain metastases."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Have any form of primary or acquired immunodeficiency syndrome, such as severe combined immunodeficiency disease or acquired immune deficiency syndrome (AIDS)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Patients who have a left ventricular ejection fraction (LVEF) < 45% or who are New York Heart Association (NYHA) Class 2 or higher."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Patients who have had another primary malignancy within the previous 3 years."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "Patients who are pregnant, parturient, or breastfeeding women."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Patients who have received a live or attenuated vaccine within 28 days of the NMA-LD regimen."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "LN-145/LN-145-S1 is an adoptive cell transfer therapy that utilizes an autologous TIL\r\n      manufacturing process, as originally developed by the NCI, for the treatment of patients with\r\n      recurrent and/or metastatic squamous cell carcinoma of the head and neck. The cell transfer\r\n      therapy used in this study involves patients receiving a NMA lymphocyte depleting preparative\r\n      regimen, followed by infusion of autologous TIL followed by the administration of a regimen\r\n      of IL-2.",
        "official_title": "A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-145/LN-145-S1) for the Treatment of Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck",
        "_phase_sort_order": 2,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Up to 24 months",
                "name": "Disease Control Rate",
                "description": "To evaluate efficacy parameters such as Disease Control Rate (DCR) using RECIST v1.1 as assessed by the Investigator",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "Duration of Response",
                "description": "To evaluate efficacy parameters such as Duration of Response (DOR) using RECIST v1.1 as assessed by the Investigator",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "Objective Response Rate",
                "description": "To evaluate the efficacy of LN-145/LN-145-S1 in patients with recurrent and/or metastatic HNSCC based on the objective response rate (ORR) using Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 as assessed by the Investigator",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 36 months",
                "name": "Overall Survival",
                "description": "To evaluate Overall Survival (OS) in patients with recurrent and/or metastatic HNSCC",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "Progression-Free Survival",
                "description": "To evaluate efficacy parameters such as Progression-Free Survival (PFS) using RECIST v1.1 as assessed by the Investigator",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 24 months",
                "name": "Safety Profile as Assessed by Incidence of Adverse Events",
                "description": "To characterize the safety profile of LN-145/LN-145-S1 in patients with metastatic and/or recurrent HNSCC",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 5,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03083873",
        "biomarkers": [],
        "classification_code": null,
        "current_trial_status_date": "2021-01-11",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV",
                    "Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C133259",
                "name": "Stage IV Head and Neck Squamous Cell Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C133253"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrent Head and Neck Squamous Cell Carcinoma",
                    "Recurrent Squamous Cell Carcinoma of the Head and Neck"
                ],
                "nci_thesaurus_concept_id": "C133709",
                "name": "Recurrent Head and Neck Squamous Cell Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C162652",
                    "C34447",
                    "C7624"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Head and Neck Squamous Cell Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C148153",
                "name": "Metastatic Head and Neck Squamous Cell Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C126465",
                    "C4104",
                    "C34447"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Squamous Cell Carcinoma of Head and Neck",
                    "Squamous Cell Carcinoma of the Head and Neck",
                    "SCCHN",
                    "HNSCC",
                    "Head and neck squamous cell carcinoma, NOS"
                ],
                "nci_thesaurus_concept_id": "C34447",
                "name": "Head and Neck Squamous Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C35850",
                    "C2929"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, SQUAMOUS CELL, MALIGNANT",
                    "Squamous Cell Carcinoma, NOS",
                    "Squamous Cell Carcinoma, conventional",
                    "Squamous Carcinoma",
                    "Malignant Epidermoid Cell Neoplasm",
                    "Squamous Cell Epithelioma",
                    "Malignant Squamous Cell Neoplasm",
                    "Malignant Squamous Cell Tumor",
                    "Epidermoid Carcinoma",
                    "Squamous Cell Carcinoma, Not Otherwise Specified",
                    "Epidermoid carcinoma, NOS",
                    "Malignant Epidermoid Cell Tumor",
                    "Squamous Cell Cancer",
                    "Epidermoid Cell Cancer"
                ],
                "nci_thesaurus_concept_id": "C2929",
                "name": "Squamous Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C3792"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7624",
                "name": "Recurrent Head and Neck Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7619",
                    "C35850",
                    "C152077"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162652",
                "name": "Recurrent Squamous Cell Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7619",
                    "C2929"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C27571",
                "name": "Head and Neck Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Head and Neck",
                    "Head and Neck Cancer",
                    "Malignant Neoplasm of Head and Neck",
                    "Malignant Tumor of Head and Neck",
                    "Malignant Head and Neck Tumor",
                    "Malignant Neoplasm of the Head and Neck",
                    "Head and neck cancer, NOS",
                    "Cancer of Head and Neck",
                    "Cancer of the Head and Neck"
                ],
                "nci_thesaurus_concept_id": "C4013",
                "name": "Malignant Head and Neck Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3077",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of the Head and Neck",
                    "Head and Neck Neoplasm (Excluding Central Nervous System)",
                    "Neoplasm of Head and Neck",
                    "Head and Neck Tumor",
                    "Tumor of Head and Neck",
                    "Neoplasm of the Head and Neck"
                ],
                "nci_thesaurus_concept_id": "C3077",
                "name": "Head and Neck Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27571",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrence",
                    "Recurrent",
                    "Recurrent Tumor",
                    "Neoplasm Recurrence"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrent Head and Neck Cancer"
                ],
                "nci_thesaurus_concept_id": "C152077",
                "name": "Recurrent Malignant Head and Neck Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C4013"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Squamous Cell Neoplasms",
                    "Epidermoid Cell Neoplasm",
                    "Squamous Cell Tumor",
                    "Epidermoid Cell Tumor"
                ],
                "nci_thesaurus_concept_id": "C3792",
                "name": "Squamous Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9305",
                    "C4798"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of Head and Neck",
                    "Carcinoma of the Head and Neck"
                ],
                "nci_thesaurus_concept_id": "C35850",
                "name": "Head and Neck Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C4013",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Recurrent Cancer",
                    "Relapsed Carcinoma",
                    "Relapsed Cancer"
                ],
                "nci_thesaurus_concept_id": "C7619",
                "name": "Recurrent Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Skin Cancer",
                    "Melanoma and Non-Melanoma Skin Cancer",
                    "Malignant Neoplasm of the Skin",
                    "Skin Cancer, Including Melanoma",
                    "Malignant Tumor of Skin",
                    "Malignant Tumor of the Skin",
                    "Skin Neoplasm, Malignant",
                    "Skin cancer, NOS",
                    "Malignant Neoplasm of Skin",
                    "Malignant Skin Tumor"
                ],
                "nci_thesaurus_concept_id": "C2920",
                "name": "Malignant Skin Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3372"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C133252",
                "name": "Cutaneous Squamous Cell Carcinoma of the Head and Neck",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4819",
                    "C34447"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epidermoid Carcinoma of the Skin",
                    "Squamous Cell Skin Carcinoma",
                    "Skin Squamous Cell Carcinoma",
                    "Cutaneous Squamous Cell Carcinoma",
                    "Epidermoid Carcinoma of Skin",
                    "Epidermoid Skin Carcinoma",
                    "Squamous Cell Carcinoma of the Skin",
                    "Squamous cell carcinoma - skin",
                    "Squamous Cell Carcinoma of Skin"
                ],
                "nci_thesaurus_concept_id": "C4819",
                "name": "Skin Squamous Cell Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2929",
                    "C4914"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Skin Cancer, Non-Melanoma",
                    "nonmelanoma skin cancer",
                    "Carcinoma of the Skin",
                    "Non-Melanoma Cancer of the Skin",
                    "Carcinoma of Skin",
                    "Non-Melanoma Cancer of Skin",
                    "Skin Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C4914",
                "name": "Non-Melanoma Skin Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2920",
                    "C2916",
                    "C7342"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Head and Neck Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C126465",
                "name": "Metastatic Head and Neck Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C35850",
                    "C170467"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Squamous cell carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C4104",
                "name": "Metastatic Squamous Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2929"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Stage (Pathological)"
                ],
                "nci_thesaurus_concept_id": "C133253",
                "name": "Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C133252"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Skin Neoplasm",
                    "Neoplasm of the Skin",
                    "Tumor of the Skin",
                    "Tumor of Skin",
                    "Skin Neoplasms",
                    "Neoplasm of Skin"
                ],
                "nci_thesaurus_concept_id": "C3372",
                "name": "Skin Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C3371"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Skin",
                    "Skin Diseases and Manifestations",
                    "Skin Disorders",
                    "Cutaneous Disorder",
                    "Dermatologic Disorder"
                ],
                "nci_thesaurus_concept_id": "C3371",
                "name": "Skin Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Skin Epithelium Neoplasm",
                    "Epithelial Skin Tumor",
                    "Skin Epithelium Tumor"
                ],
                "nci_thesaurus_concept_id": "C7342",
                "name": "Epithelial Skin Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709",
                    "C3372"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170467",
                "name": "Metastatic Malignant Head and Neck Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4013",
                    "C36263"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "C-145-03",
        "active_sites_count": 5,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Pharmaceutical Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Drug",
                            "Pharmacological Substance",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Immune Cell",
                            "Antineoplastic Immune Cells"
                        ],
                        "nci_thesaurus_concept_id": "C129826",
                        "name": "Antineoplastic Immune Cell",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821",
                            "C142078",
                            "C129820"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "ACT Agent",
                            "Adoptive Cell Transfer Agent",
                            "Adoptive Cell-based Agent",
                            "Adoptive Cellular Therapy Agent",
                            "Adoptive Cell Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C142078",
                        "name": "Adoptive Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C307",
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Tumor Infiltrating Lymphocytes",
                            "Tumor Infiltrating Lymphocytes"
                        ],
                        "nci_thesaurus_concept_id": "C28699",
                        "name": "Tumor Infiltrating Lymphocyte Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C28681",
                            "C129826"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biologics",
                            "Immunologic, Immunochemical",
                            "Biological Products",
                            "Immunologics",
                            "Biologicals",
                            "Biopharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Antiproliferative Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Anti-Tumor Drugs",
                            "Antineoplastics",
                            "Cancer Drug",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Cancer Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biomodulators",
                            "Immunomodulatory Agent",
                            "Immune Regulators",
                            "Biological Response Modifier",
                            "Immune Modulators",
                            "Immunopotentiators",
                            "Immune Mediators",
                            "Immunotherapy Agent",
                            "Immunotherapeutic Agent",
                            "BRM",
                            "Immunomodulators",
                            "Immunomodulating Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Autologous T-cells"
                        ],
                        "nci_thesaurus_concept_id": "C28681",
                        "name": "Therapeutic Autologous Lymphocytes",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C142078"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C135634",
                        "name": "Autologous Tumor Infiltrating Lymphocytes LN-145",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C28699"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic BRM",
                            "Antineoplastic Biological Response Modifier",
                            "Anti-cancer Immunotherapeutic",
                            "Antineoplastic Immunotherapeutic"
                        ],
                        "nci_thesaurus_concept_id": "C129820",
                        "name": "Antineoplastic Immunomodulating Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C308"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Cohort 1",
                "description": "Treatment with LN-145, Generation 1 (Gen 1), non-cryopreserved TIL",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort 2",
                "description": "Treatment with LN-145 Generation 2 (Gen 2), cryopreserved TIL",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort 3",
                "description": "Treatment with LN-145 Generation 3 (Gen 3), cryopreserved TIL",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort 4",
                "description": "Treatment with LN-145-S1 cryopreserved TIL",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Cohort 5",
                "description": "LN-145 cryopreserved/LN-145-S1 cryopreserved TIL re-treatment",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2017-00925",
        "why_study_stopped": null,
        "brief_summary": "Multicenter, multicohort, non-randomized, prospective, open label, interventional study\r\n      evaluating adoptive cell therapy (ACT) with autologous tumor infiltrating lymphocytes (TIL)\r\n      infusion (LN-145/LN-145-S1) followed by IL-2 after a non-myeloablative (NMA) lymphodepletion\r\n      preparative regimen for the treatment of patients with recurrent and/or metastatic squamous\r\n      cell carcinoma of the head and neck",
        "brief_title": "Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck",
        "status_history": [
            {
                "status_date": "2021-01-11T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2017-01-09T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 55,
        "_current_trial_status_sort_order": 7,
        "start_date": "2017-01-09",
        "record_verification_date": "2021-01-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2022-06-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]